Anebulo PharmaceuticalsANEB
那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
01/01 08:00 (UTC+8)
Anebulo PharmaceuticalsANEB
0
0
(0%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 2,260 | 2,331 | 1,892 | - | - | - | - | 2,761 | 2,543 | 2,494 |
研發費用 | 810 | 1,126 | 638 | 1,221 | 1,315 | 468 | 748 | 1,063 | 1,270 | 1,417 |
推銷及管理費用 | 1,450 | 1,205 | 1,254 | 1,368 | 1,097 | 873 | 916 | 1,698 | 1,273 | 1,077 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -2,260 | -2,331 | -1,892 | -2,588 | -2,412 | -1,340 | -1,664 | -2,760 | -2,544 | -2,494 |
其他收入及費用 | 119 | 203 | 461 | 185 | 271 | 50 | 70 | 75 | 63 | -1 |
利息費用 | 17 | 17 | 245 | 60 | 60 | 60 | 60 | 32 | - | - |
稅前純益 | -2,158 | -2,145 | -1,676 | -2,463 | -2,201 | -1,350 | -1,654 | -2,717 | -2,481 | -2,496 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -2,158 | -2,145 | -1,676 | -2,463 | -2,201 | -1,350 | -1,654 | -2,717 | -2,481 | -2,496 |
基本每股稅後盈餘(元) | -0.05 | -0.05 | -0.04 | -0.09 | -0.08 | -0.05 | -0.06 | -0.11 | -0.10 | -0.10 |
稀釋每股稅後盈餘(元) | -0.05 | -0.05 | -0.03 | -0.09 | -0.08 | -0.05 | -0.07 | -0.10 | -0.10 | -0.10 |
基本平均股數(千股) | 41084.00 | 41084.00 | 41084.00 | 27415.00 | 25933.00 | 25934.00 | 25933.00 | 25789.00 | 25633.00 | 25633.00 |
稀釋平均股數(千股) | 41084.00 | 41084.00 | 41084.00 | 27415.00 | 25933.00 | 25934.00 | 25933.00 | 25789.00 | 25633.00 | 25633.00 |
還原基本每股稅後盈餘(元) | -0.05 | -0.05 | -0.04 | -0.09 | -0.08 | -0.05 | -0.06 | -0.11 | -0.10 | -0.10 |
還原稀釋每股稅後盈餘(元) | -0.05 | -0.05 | -0.03 | -0.09 | -0.08 | -0.05 | -0.07 | -0.10 | -0.10 | -0.10 |
還原基本平均股數(千股) | 41,084 | 41,084 | 41,084 | 27,415 | 25,933 | 25,934 | 25,933 | 25,789 | 25,633 | 25,633 |
還原稀釋平均股數(千股) | 41,084 | 41,084 | 41,084 | 27,415 | 25,933 | 25,934 | 25,933 | 25,789 | 25,633 | 25,633 |
EBITDA(千元) | -2,124 | -2,111 | -1,186 | -2,343 | -2,081 | -1,230 | -1,534 | -2,653 | -2,481 | -2,496 |